摘要
Objective Peritoneal fibrosis (PF) is commonly induced by bioincompatible dialysate exposure during peritoneal dialysis, but the underlying mechanisms remain elusive. This study aimed to investigate the roles of peroxisome proliferator-activated receptor gamma (PPAR gamma) in PF pathogenesis. @@@ Methods Rat and cellular PF models were established by high glucose dialysate and lipopolysaccharide treatments. Serum creatinine, urea nitrogen, and glucose contents were detected by ELISA. Histological evaluation was done through H&E and Masson staining. GLUT1, PPAR gamma, and other protein expression were measured by qRT-PCR, western blotting, and IHC. PPAR gamma and GLUT1 subcellular distribution were detected using confocal microscopy. Cell proliferation was assessed by MTT and Edu staining. @@@ Results Serum creatinine, urea nitrogen and glucose, and PPAR gamma and GLUT1 expression in rat PF model were reduced by PPAR gamma agonists Rosiglitazone or 15d-PGJ2 and elevated by antagonist GW9662. Rosiglitazone or 15d-PGJ2 repressed and GW9662 aggravated peritoneal fibrosis in rat PF model. PPAR gamma and GLUT1 were mainly localized in nucleus and cytosols of peritoneal mesothelial cells, respectively, which were reduced in cellular PF model, enhanced by Rosiglitazone or 15d-PGJ2, and repressed by GW9662. TGF-beta and a-SMA expression was elevated in cellular PF model, which was inhibited by Rosiglitazone or 15d-PGJ2 and promoted by GW9662. PPAR gamma silencing reduced GLUT1, elevated a-SMA and TGF-b expression, and promoted peritoneal mesothelial cell proliferation, which were oppositely changed by PPAR gamma overexpression. @@@ Conclusion PPAR gamma inhibited high glucose-induced peritoneal fibrosis progression through elevating GLUT1 expression and repressing peritoneal mesothelial cell proliferation.
学科与关键词
- Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosisLuo, Qimei; Liu, Mi; Tan, Yanhong; Chen, Jinzhong; Zhang, Wei; Zhong, Shaoxin; Pan, Jianyi; Zheng, Qingkun; Gong, Lewei; Su, Lijuan; Jia, Zhanjun*; Dou, Xianrui*Frontiers in Pharmacology, 2022, 13: 1004619.被引 1
- Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axisZhang, Ying; Feng, Weidong; Peng, Xuan; Zhu, Liya; Wang, Zebin; Shen, Hua; Chen, Chaojiang; Xiao, Long; Li, Shuting; Zhao, Yunyi; Lin, Muyi; Huang, Ying*; Long, Haibo*; Liang, Jianbo*Laboratory Investigation, 2022, 102(12): 1346-1354.被引 13
- Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 InflammasomeLuo, Qimei; Hu, Qinghua; Zheng, Qingkun; Gong, Lewei; Su, Lijuan; Ren, Baojun; Ju, Yongle; Jia, Zhanjun*; Dou, Xianrui*Frontiers in Medicine, 2021, 8: 675363.被引 9
